baber/WOPTO huggingface dataset:
Patent NZ-532002-A (NZ)
Title: Hogger apparatus with inclined drum having screening apertures on side wall, and drum rotating reducing means
Inventor: SHARP RODNEY WARWICK
IPC: B02C17/02
Filed: 2004-03-29
Abstract: The apparatus includes an inclined drum 40 which is open at its upper end and has screening apertures on its side wall. A rotating reducing means 45 is provided within and proximate to the lower end of the drum - so as to reduce the size of raw material with which it comes in contact with.
Patent NZ-532483-A (NZ)
Title: Conventional timber drying kiln condensor
Inventor: FOGARTY JOHN EDWARD
IPC: F27D19/00
Filed: 2004-04-23
Abstract: A kiln condensing apparatus is for use in association with a conventional vented timber drying kiln. The apparatus includes at least one external chamber having least one air inlet means adapted to extract, in use, humid air from the kiln into the chamber, a condensing means configured and arranged in or about the chamber, in use, for cooling the humid air to below the dew point sufficient to condense moisture in the humid air into liquid form and allowing for the removal thereof and at least one air outlet means adapted, in use, to extract the dehumidified air from the external chamber back into the kiln. The apparatus also includes a control means for controlling the atmospheric drying conditions within the kiln.
Patent NZ-535024-A (NZ)
Title: 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
Inventor: TANI KOUSUKE
IPC: A61P11/06
Filed: 2003-03-04
Abstract: 8-Azaprostaglandin of formula (I-A1), pharmacologically acceptable salts thereof or cyclodextrin clathrates of the same are disclosed, wherein the variables are as defined in the specification. Because of strongly binding to PGE receptor subtype EP2, these compounds are useful in preventing and/or treating immune diseases, allergic diseases, neuronal cell death, dysmenorrhea, premature birth, abortion, baldness, retinal neuropathy such as glaucoma, erectile dysfunction, arthritis, pulmonary injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, hepatic injury, acute hepatitis, liver cirrhosis, shock, nephritis, renal failure, circulatory diseases, systemic inflammatory response syndrome, sepsis, hemophagocytosis syndrome, macrophage activation syndrome, Still's disease, Kawasaki disease, burn, systemic granuloma, ulcerative colitis, Crohn's disease, hypercytokinemia at dialysis, multiple organ failure and bone diseases.
Patent NZ-537098-A (NZ)
Title: Mounting system for mounting of shelving having a support panel and hook
Inventor: ARMARI DANIEL OTTORINO
IPC: A47B96/06
Filed: 2003-05-30
Abstract: A mounting system incorporates a supporting panel (1) and a mount (4). The supporting panel incorporates cavities (2, 3) having an aperture (10) in a front face of the panel. The cavity widens from the aperture to a hook receiving portion (11) having upper and lower surfaces, with at least the upper surface incorporating a recess (39) and the lower surface incorporating an inclined bearing surface (38). In use the hook is arranged to be located in the hook receiving portion (11), with a distal portion (15B) of the hook being located within the aperture and rotated so that the hook passes the aperture and locates within the hook receiving portion. Further, to resist withdrawal of the hook from the cavity, the distal and proximal portions are arranged to abut respective ones of the upper and lower surfaces and to become wedged between those surfaces.
Patent NZ-538565-A (NZ)
Title: Treating spent caustic refinery effluents in a submerged combustion gas evaporator
Inventor: DUESEL BERNARD F
IPC: B01D17/038
Filed: 2003-09-02
Abstract: A method for treating caustic effluents is disclosed, which comprises: supplying a caustic effluent to a submerged combustion gas evaporator; and supplying combustion gas to the submerged combustion gas evaporator at a temperature and quantity high enough to vaporize water and volatile constituents in the caustic effluent and concentrate a constituent of the caustic effluent, wherein the combustion gas supplied to the submerged combustion gas evaporator contains carbon dioxide and including the step of reacting the carbon dioxide with a caustic constituent of the caustic effluent to covert the caustic constituent to a carbonate, thereby sequestering carbon dioxide from the combustion gas. The method is particularly suitable for treating caustic effluents from a petroleum refinery, wherein the effluent includes an aqueous caustic liquid and oil and wherein oil in the waste liquid is separated from the aqueous constituent before, during or after concentration.
Patent NZ-539295-A (NZ)
Title: Method for purifying by nanofiltration an aqueous sugary solution containing monovalent and polyvalent anions and cations
Inventor: THEOLEYRE MARC-ANDRE
IPC: C13B20/14
Filed: 2003-08-27
Abstract: A purification method by nanofiltration of an aqueous solution containing one or several sugars, multivalent cations, monovalent metallic cations, monovalent anions and multivalent inorganic anions and/or organic acid anions, characterized in that it comprises the following steps which consist in: (a) replacement of at least a part of the multivalent cations and/or the mineral multivalent anions and organic acid anions respectively with monovalent metal cations and/or monovalent anions in order to obtain an aqueous solution depleted in multivalent cations and/or multivalent inorganic anions and organic acid anions, and containing the monovalent metal cations and monovalent anions; (b) nanofiltration of the solution resulting from step (a) to obtain as a retentate, a sugary aqueous juice enriched in sugars, in multivalent cations and in multivalent inorganic anions and/or in organic acid anions, and as a permeate, an aqueous effluent enriched in monovalent anions and monovalent metal cations; (c) demineralization of at least a part of the retentate obtained in (b), with a cation-exchange resin of which the counter-ion is H+ and an anion-exchange resin of which the counter-ion is OH-, these reins thus charging themselves respectively in residual cations of the retentate; and (d) regeneration of the cation-exchange resin by means of an inorganic acid of which the anion is of the same type as the monovalent anions present in the initial aqueous solution, and on the other hand, the anion-exchange resin by means of an inorganic base of which the cation is the same type as the monvalent metal cations present in the initial aqueous solution, which produces regenerated exchange resins and two regeneration effluents mainly containing monovalent anions and monovalent metal cations. Also described is the use of the above method in the purification of a whey and a permeate resulting from the ultrafiltration of a whey, sugar beetroot juice, sugarcane juice, chicory juice or Jerusalem Artichokes. The whey, permeate or juice comprises Ca2+ and Mg2+ ions, Cl- anions, Na+ and K+ cations and anions selected mainly in the group consisting in the phosphate and sulphate anions, anions from organic acids and their mixtures.
Patent NZ-544217-A (NZ)
Title: Ryegrass pollen-specific promoters and expression constructs
Inventor: SPANGENBERG GERMAN
IPC: C12N15/82
Filed: 2004-06-18
Abstract: Disclosed is a nucleic acid molecule capable of modifying pollen-specific expression, constructs including the molecule and methods of using the molecule.
Patent NZ-545140-A (NZ)
Title: Squeeze receptacle for foodstuff formed from two dimensional blank including transparent or translucent liquid tight material
Inventor: D AMATO GIANFRANCO
IPC: B65D65/40
Filed: 2004-06-22
Abstract: A squeeze receptacle, particularly for holding a foodstuff (2), has a wall (6) with at least one layer. The cup has a removal opening (7) with an opening edge (8) and is closed at its end (9) located opposite the removal opening (7). At least the receptacle wall (6) is made of a two-dimensional blank that, for forming a continuous receptacle wall, is joined to itself. The aim of the invention is to provide a squeeze receptacle (1) of the aforementioned type that, while having a simple and cost-effective design and while preserving all the advantages of prior art receptacles, enables the inside of the receptacle to be inspected. To this end, the squeeze receptacle (1) is made, at least in part, from a transparent or translucent, in particular, liquid-tight and fluid-tight material that, for forming the receptacle (1), can be shaped and, after shaping, is dimensionally stable.
Patent NZ-545196-A (NZ)
Title: Improved accoustic/shock wave attenuating assembly
Inventor: WADDELL JOHN L
IPC: F42D5/045
Filed: 2004-02-27
Abstract: An assembly (20) for attenuating shock waves is made of two flexible sheets arranged one over the other and joined by a plurality of seams (22), the seams being arranged to form cells or recesses in the space between the sheets when joined together. The cells or recesses are filled with a shock attenuating material, and the assembly is sufficiently flexible to assume any desired shape. The assembly may be cut along the seams and the shock attenuating material remains confined within the cells.
Patent NZ-547722-A (NZ)
Title: Biological fertilizer
Inventor: VAN DER WEIDE WILLIBRORDUS AUGUSTINUS
IPC: C05F1/00
Filed: 2003-11-20
Abstract: Disclosed are methods for the preparation of a biological fertilizer comprising subjecting whey to a first fermentation step and the addition of a carrier material to the fermented whey and a biological fertilizer obtainable by the method. The biological fertilizer can be used as a replacement of the present artificial fertilizers thereby reducing many of the environmental problems associated with these artificial fertilizers. In addition, the biological fertilizer according to the present invention can be used in the field of biological agriculture for which, until the present biological fertilizer, no fertilizers were available.
Patent NZ-551077-A (NZ)
Title: Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
Inventor: JAROSKOVA LIBUSE
IPC: C07D211/76
Filed: 2005-04-29
Abstract: Disclosed is a compound for use as a medicine of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1 or 2; L represents a C1-3alkanediyl linker optionally substituted with one or two substituents selected from C1-4-alkyl, C1-3alkyloxy-C1-4alkyl-, hydroxy-C1-4alkyl, hydroxy, C1-3alkyloxy- or phenyl-C1-4alkyl; M represents a direct bond or a C1-3alkanediyl linker optionally substituted with one or two substituents selected from hydroxy, C1-4alkyl or C1-4alkyloxy; and wherein the rest of the substituents are disclosed within the specification.
Patent NZ-552306-A (NZ)
Title: Animal tag applicator and tags therefor
Inventor: LYND MALCOLM NORMAN
Filed: 2006-12-20
Abstract: An animal tag applicator (1) has handles (2) and (3) pivotally connected together and extending to respective jaws (6) and (7) for dispensing an ear tag (10) to be engaged about an animal's ear (39). The tags are in the form of an elongate, longitudinally connected, longitudinally directed strip which can be accommodated within the hollow handle (2). A slider (17) has a pusher (18) engaged with the front-most tag (10A) to move it into the dispensing position where its male portion is engaged by the top jaw (7) and a cutting means (31) severs the connection between the front-most tag and the immediately following tag. A releasable stop member (42) engages the front-most tag before it is dispensed. A lost motion slot (43) enables the cutting means to be raised before the pusher engages with the next tag to move it into the dispensing position.
Patent NZ-567495-A (NZ)
Title: Compositions comprising the acid catalysed condensation product of a fluorosilane with an aminosilane
Inventor: DANZEBRINK ROLF
IPC: C04B41/49
Filed: 2006-10-18
Abstract: Disclosed is a non-aqueous reactive composition which comprises an acid catalysed reaction product of: (a) at least one fluorosilane of the general formula Rtf-SiX3, wherein X is selected from the group of alkoxy, halide, oxime, carboxyl, phenoxide and polyether; Rtf is a straight, branched or cyclic residue (as defined herein) which contains a linear or branched perfluoralkylene group; and (b) at least one aminosilane of the general formula RaSiR3R4R5; where Ra is a straight, branched or cyclic alkyl residue comprising 1 to 7 carbon atoms and at least one primary, secondary, ternary or quaternary, preferably protonated, amino group; R3 and R4 are independently selected from Ra, OR6 and/or R6; R5 is OR6; and R6 is a straight, branched or cyclic alkyl residue comprising 1 to 3 carbon atoms. Also disclosed is the use of the compositions as defined above as surface protective agents for use on substrates such as stone, wood or textiles.
Patent NZ-567501-A (NZ)
Title: Laser hair removal device
Inventor: SOHI DANIEL
IPC: A61B17/00
Filed: 2006-09-20
Abstract: Disclosed is a laser hair removal device for exposing hair follicles to laser radiation to facilitate hair removal. The device includes a body housing, a hair removal laser capable of emitting radiation at a wavelength suitable for hair removal, a further light emitting element arranged to emit a high intensity beam of radiation at a wavelength selected to stimulate an eye blinking reflex without injuring the eye. The light emitting element emits light in generally the same direction as the hair removal laser. The laser hair removal device further includes a control circuit which, at or following power up of the device, and prior to actuation of the hair removal laser, turns on the further light emitting element to emit a beam of radiation, to thereby deter a user from aiming the device towards their eye.
Patent NZ-568057-A (NZ)
Title: Mask and components thereof
Inventor: BERTHON-JONES MICHAEL
IPC: A61M16/06
Filed: 2003-11-06
Abstract: A cushion assembly (400) for a mask used for treatment of sleep disordered breathing, the cushion assembly comprising: a first layer (440) constructed of an elastomer material, the first layer including a front side adapted for connection to a body of the mask and a rear side opposite the front side; and a second layer (430) constructed of a foam material and being connected to the first layer and extending from the front side of the first layer toward the rear side, the second layer defining a cushion shape and being adapted to engage a wearer's face and form a seal between the mask and the wearer's face upon engagement and compress upon application of a force to the cushion assembly.
Patent NZ-569577-A (NZ)
Title: Device for filling cigarette tubes with tobacco
Inventor: ANDERSEN JULIA C
IPC: A24C5/42
Filed: 2007-01-19
Abstract: A portion of tobacco 10, just enough to fill a cigarette, is separated from a compressed block of tobacco 1 by a portioning and separating system 130, 150, then filled into a cigarette tube 11. The tobacco block is transported toward the portioning and separating system to be apportioned by a transport arrangement 2.
Patent NZ-570332-A (NZ)
Title: Anti-infective solution comprising a pyrido(3,2,1-IJ)-benzoxadiazine compound (such as marbofloxacin), a stabilizing agent, and a solubilization agenet
Inventor: MOREAU MARINETTE
IPC: A61K47/02
Filed: 2007-01-24
Abstract: Disclosed is an anti-infection solution, which comprises: (i) 10-30% (w/w) of a compound of the pictured formula, or a pharmaceutically acceptable salt thereof, wherein X is hydrogen, halogen, or hydroxy, R2 is alkyl or cycloalkyl, and R1 is a ring group selected from the list given in the specification, (ii) benzyl alcohol, and (iii) at least one organic acid or an ester thereof, in a pharmaceutically acceptable carrier. Also disclosed is the use of the composition to treat infections in animals.
Patent NZ-574207-A (NZ)
Title: Pyrazole derivatives as cytochrome p450 inhibitors
Inventor: PLANKEN SIMON PAUL
IPC: A61K31/4155
Filed: 2007-06-25
Abstract: Disclosed are pyrazole derivatives of formula (I) or pharmaceutically acceptable salts or solvates thereof wherein the substituents are disclosed in the specification. Also disclosed is the use of the compounds of formula (I) in the manufacture of a medicament for the treatment of HIV and as cytochrome P450 inhibitors.
Patent NZ-576648-A (NZ)
Title: Soffit bracket to support soffit and fascia with complementary engagement features
Inventor: RUSSELL KEITH MICHAEL
IPC: E04C1/39
Filed: 2008-08-06
Abstract: A soffit bracket is disclosed that supports both a soffit panel and a fascia. A first end is adapted for association with a feature of a building and is typically the end that is attached to a building wall ribbon board. The second end of the bracket is also adapted for association with building features and is typically fastened to the end of a rafter in side on relationship. Shaped features are provided along the bracket between the ends adapted to engage complementary features of a soffit to be supported by the bracket. An upstand is provided at the second end of the bracket for association with a lip projecting from the upper region of a fascia so that the latter is supported by the bracket. A region is provided below the upstand to support a lower region of a fascia. (62) Divided Out of 567614
Patent NZ-580444-A (NZ)
Title: Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
Inventor: APELIAN DAVID
IPC: A61K39/00
Filed: 2008-01-17
Abstract: Compositions and uses thereof of: i) A yeast vehicle that comprises a nucleic acid which encodes a polypeptide comprising a Bcr-Abl junction sequence; ii) A yeast vehicle and polypeptide comprising a Bcr-Abl junction sequence; iii) A yeast vehicle transformed with a nucleic acid which encodes a polypeptide comprising Bcr-Abl with one of the escape mutations: T315I, E255K and M351T; and iv) A yeast vehicle and polypeptide comprising Bcr-Abl with one of the escape mutations: T315I, E255K and M351T. The compositions are used for the treatment of cancer.
Patent NZ-580976-A (NZ)
Title: Smoking article with controlled flavor release
Inventor: KARLES GEORGIOS D
IPC: A24C5/56
Filed: 2008-06-06
Abstract: Disclosed is a smoking article (10) with a controlled flavor release product (16). The controlled flavor release product includes a first time-release flavourant (24) which is delivered at a first time and triggered by a first mechanism, and a second time-release flavourant (26) delivered at a second time, and triggered by a second mechanism. The first and second time-released flavourants are incorporated into controlled release microcapsules, each microcapsule containing the first time-released flavorant or the second time-released flavorant. The controlled flavor release product is a film or a lip balm type formulation that is applied to the downstream end (14) of a smoking article.
Patent NZ-583924-A (NZ)
Title: Myelin basic protein (MBP) peptide composition for treatment of multiple sclerosis (MS)
Inventor: WRAITH DAVID
IPC: A61K38/17
Filed: 2008-10-30
Abstract: A composition that comprises the myelin basic protein peptides MBP 30-44, MBP 83-99, MBP 131-145 and MBP 140-154. The composition can be used for treating multiple sclerosis and optic neuritis associated with multiple sclerosis.
Patent NZ-590126-A (NZ)
Title: Compounds having antiviral properties
Inventor: DEADMAN JOHN JOSEPH
IPC: A61K31/519
Filed: 2009-07-02
Abstract: Disclosed is a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Examples of compounds of formula (I) are: 3-benzyloxy-9-bromo-7-morpholin-4-yl-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylic acid [3-(4-fluoro-phenyl)-2-oxo-propyl]-amide and 2-[5-(4-fluoro-benzyl)-oxazol-2-yl]-3-hydroxy-9-iodo-7-morpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one. The compounds are useful for the treatment or prophylaxis of a viral infection such as HIV or SIV and other integrase resistant viral strains. Pharmaceutical compositions comprising a compound of formula (I) are also disclosed.
Patent NZ-592226-A (NZ)
Title: Use of dithiin tetracarboximides for treating phytopathogenic fungi for protecting plants
Inventor: SEITZ THOMAS
IPC: A01N43/90
Filed: 2009-10-06
Abstract: The disclosure relates to the use of dithiine tetracarboximides represented by structural formula (I) for treating phytopathogenic fungi, wherein the variables are as defined in the specification. The disclosure also related to a method for treating phytopathogenic fungi for pest management, and pest management agents comprising said dithiine tetracarboximides.
Patent NZ-594071-A (NZ)
Title: Controlled release formulations comprising morphine sulphate for continuous treatment of pain
Inventor: NDERSEN CHRISTINE
IPC: A61K9/20
Filed: 2010-01-26
Abstract: The disclosure relates to the use of a pharmaceutical composition comprising: (a) a matrix composition comprising: (i) an active drug substance; and (ii) at least one polyglycol, said matrix composition having a cylindrical shape optionally with tapered end(s), said matrix being surrounded by:(b) a coating having at least one opening exposing one surface of said matrix, said coating being substantially impermeable to an aqueous medium; in the manufacture of a medicament for the continuous treatment of pain, wherein the medicament is formulated to be administered once daily for at least 3 days, so as to relieve or ameliorate pain for at least 24 hours after daily intake and the average number of daily Break Through Pain episodes determined in at least 30 steady state individuals is at the most 2. The disclosure particularly relates to the use of a pharmaceutical composition comprising morphine sulphate as the active drug, a mixture of polyethylene oxide 200,000 and polyethylene oxide 300,000 as polyglycol, poloxamer as plasticizer, mannitol as stabilizer, a mixture of carrageenan and hydroxypropylmethyl cellulose as gelling agent, butylated hydroxytoluene as antioxidant and a mixture of polylactic acid and polyethylene oxide as the coating for the continuous treatment of pain; and it also relates to the use of a pharmaceutical composition comprising morphine sulphate as the active drug, polyethylene oxide 300,000 as polyglycol, poloxamer as plasticizer, a mixture of mannitol and butylated hydroxytoluene as stabilizer and a mixture of ethylcellulose, cetostearyl alcohol and titanium dioxide as the coating for the continuous treatment of pain as described herein.
Patent NZ-595934-A (NZ)
Title: A topical parasiticide composition
Inventor: REYNOLDS LOUISE
IPC: A01N49/00
Filed: 2010-03-29
Abstract: 595934 Disclosed herein is a topical parasiticide composition comprising: (i) a phenyl pyrazole insecticide; and/or a neonicotinoid; (ii) a macrocylic lactone and/or an aminoacetonitrile derivatives; (iii) an Insect Growth Regulator; and (iv) a 2-acyl-4-oxo-1,2,3,6,7,11b-4H- pyrazino [2, 1a] isoquinoline derivative.